Insider · CIK 0001827500
HighCape Capital, LLC
Files at ELUT (AZIYO BIOLOGICS, INC.). First filing -, latest -.
In brief
HighCape Capital, LLC files SEC Form 4 as 10% owner and director at ELUT (AZIYO BIOLOGICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; HighCape Capital, LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | ELUT AZIYO BIOLOGICS, INC. | XIn-the-money exercise Class A Common Stockindirect: See footnotes | +2,101,577 | $1.43 | $3.0M | 9,100,232 | Aug 1, 2024 |
| Jul 30, 2024 | ELUT AZIYO BIOLOGICS, INC. | XIn-the-money exercise Warrants (right to buy)derivativeindirect: See footnote | -2,101,577 | $0.00 | $0 | 0 | Aug 1, 2024 |
| Dec 28, 2023 | ELUT AZIYO BIOLOGICS, INC. | JOther Class A Common Stockindirect: See footnotes | -1,436,077 | - | - | 6,998,655 | Jan 8, 2024 |
| Dec 28, 2023 | ELUT AZIYO BIOLOGICS, INC. | JOther Warrants (right to buy)derivativeindirect: See footnote | -2,154,116 | - | - | 2,101,577 | Jan 8, 2024 |
Questions about HighCape Capital, LLC
Answered from the filings on this page, as of the latest one.
Is HighCape Capital, LLC buying or selling?
HighCape Capital, LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did HighCape Capital, LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and HighCape Capital, LLC has 0.
Where does HighCape Capital, LLC file Form 4?
HighCape Capital, LLC has filed Form 4 at ELUT (AZIYO BIOLOGICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.